These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19339596)

  • 1. A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses.
    Deshpande A; Kawai H; Metherate R; Glabe CG; Busciglio J
    J Neurosci; 2009 Apr; 29(13):4004-15. PubMed ID: 19339596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The soluble extracellular fragment of neuroligin-1 targets Aβ oligomers to the postsynaptic region of excitatory synapses.
    Dinamarca MC; Di Luca M; Godoy JA; Inestrosa NC
    Biochem Biophys Res Commun; 2015 Oct; 466(1):66-71. PubMed ID: 26325471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
    Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
    PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer's disease.
    Marcatti M; Fracassi A; Montalbano M; Natarajan C; Krishnan B; Kayed R; Taglialatela G
    Cell Mol Life Sci; 2022 Apr; 79(4):222. PubMed ID: 35377002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes.
    Micci MA; Krishnan B; Bishop E; Zhang WR; Guptarak J; Grant A; Zolochevska O; Tumurbaatar B; Franklin W; Marino C; Widen SG; Luthra A; Kernie SG; Taglialatela G
    Mol Neurodegener; 2019 Jun; 14(1):25. PubMed ID: 31200742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.
    Brito-Moreira J; Lourenco MV; Oliveira MM; Ribeiro FC; Ledo JH; Diniz LP; Vital JFS; Magdesian MH; Melo HM; Barros-Aragão F; de Souza JM; Alves-Leon SV; Gomes FCA; Clarke JR; Figueiredo CP; De Felice FG; Ferreira ST
    J Biol Chem; 2017 May; 292(18):7327-7337. PubMed ID: 28283575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
    Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
    J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease.
    Paula-Lima AC; Brito-Moreira J; Ferreira ST
    J Neurochem; 2013 Jul; 126(2):191-202. PubMed ID: 23668663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated Aβ Oligomers.
    Wilcox KC; Marunde MR; Das A; Velasco PT; Kuhns BD; Marty MT; Jiang H; Luan CH; Sligar SG; Klein WL
    PLoS One; 2015; 10(4):e0125263. PubMed ID: 25928376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology.
    Bjorklund NL; Reese LC; Sadagoparamanujam VM; Ghirardi V; Woltjer RL; Taglialatela G
    Mol Neurodegener; 2012 May; 7():23. PubMed ID: 22640423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity.
    Peters C; Espinoza MP; Gallegos S; Opazo C; Aguayo LG
    Neurobiol Aging; 2015 Mar; 36(3):1369-77. PubMed ID: 25599875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons.
    Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F
    J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
    Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
    FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer's disease.
    Taniguchi K; Yamamoto F; Amano A; Tamaoka A; Sanjo N; Yokota T; Kametani F; Araki W
    Neurosci Res; 2022 Jul; 180():90-98. PubMed ID: 35257837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Live Imaging of Multiple Endogenous Proteins Reveals a Mechanism for Alzheimer's-Related Plasticity Impairment.
    Cook SG; Goodell DJ; Restrepo S; Arnold DB; Bayer KU
    Cell Rep; 2019 Apr; 27(3):658-665.e4. PubMed ID: 30995464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-β peptide oligomers.
    Nunes-Tavares N; Santos LE; Stutz B; Brito-Moreira J; Klein WL; Ferreira ST; de Mello FG
    J Biol Chem; 2012 Jun; 287(23):19377-85. PubMed ID: 22505713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
    Habiba U; Merlin S; Lim JKH; Wong VHY; Nguyen CTO; Morley JW; Bui BV; Tayebi M
    J Alzheimers Dis; 2020; 76(3):1135-1150. PubMed ID: 32597800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.
    Zhao WQ; Santini F; Breese R; Ross D; Zhang XD; Stone DJ; Ferrer M; Townsend M; Wolfe AL; Seager MA; Kinney GG; Shughrue PJ; Ray WJ
    J Biol Chem; 2010 Mar; 285(10):7619-32. PubMed ID: 20032460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.